2007
DOI: 10.1016/s1701-2163(16)32685-8
|View full text |Cite|
|
Sign up to set email alerts
|

RETIRED: Pre-conceptional Vitamin/Folic Acid Supplementation 2007: The Use of Folic Acid in Combination With a Multivitamin Supplement for the Prevention of Neural Tube Defects and Other Congenital Anomalies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
160
2
16

Year Published

2009
2009
2021
2021

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 262 publications
(181 citation statements)
references
References 68 publications
1
160
2
16
Order By: Relevance
“…The American College of Obstetricians and Gynecologists issued its practice guideline in 2003 and had very similar recommendations, including 0.4 mg for all women and 4 mg for women at higher risk. 49 The joint Society of Obstetricians and Gynaecologists of Canada and Motherisk guideline 50 had 10 components to their practice guideline. These were to recommend (1) education for all women of reproductive age about folate, (2) women maintain a healthy diet, (3) consumption of only one dose of a multivitamin, (4) that folic acid and multivitamins be widely available, (5) that 5 mg be given to not only prevent recurrence of NTDs but also cleft lip/palate, heart defects, limb defects, urinary tract abnormalities, and hydrocephalus, (6) that 5 mg of folic acid will not mask vitamin B12 deficiency, (7) primary prevention could be accomplished in one of three ways, with 0.4 -1 mg/day from vitamins and food, or 5 mg/day for high-risk groups (including certain ethnic groups) or those who have a poor lifestyle or evidence of poor compliance with medication use, (8) increased food fortification to 300 g/100 g flour, (9) the Canadian government consider increasing fortification with other vitamins, and (10) the organization of a consensus conference on the use of folic acid and multivitamins for the prevention of congenital anomalies.…”
Section: Are There Other Nutrients That Could Further Reduce Risks Ofmentioning
confidence: 99%
“…The American College of Obstetricians and Gynecologists issued its practice guideline in 2003 and had very similar recommendations, including 0.4 mg for all women and 4 mg for women at higher risk. 49 The joint Society of Obstetricians and Gynaecologists of Canada and Motherisk guideline 50 had 10 components to their practice guideline. These were to recommend (1) education for all women of reproductive age about folate, (2) women maintain a healthy diet, (3) consumption of only one dose of a multivitamin, (4) that folic acid and multivitamins be widely available, (5) that 5 mg be given to not only prevent recurrence of NTDs but also cleft lip/palate, heart defects, limb defects, urinary tract abnormalities, and hydrocephalus, (6) that 5 mg of folic acid will not mask vitamin B12 deficiency, (7) primary prevention could be accomplished in one of three ways, with 0.4 -1 mg/day from vitamins and food, or 5 mg/day for high-risk groups (including certain ethnic groups) or those who have a poor lifestyle or evidence of poor compliance with medication use, (8) increased food fortification to 300 g/100 g flour, (9) the Canadian government consider increasing fortification with other vitamins, and (10) the organization of a consensus conference on the use of folic acid and multivitamins for the prevention of congenital anomalies.…”
Section: Are There Other Nutrients That Could Further Reduce Risks Ofmentioning
confidence: 99%
“…3 H-FA uptake in both NTB and DTB cells was found to be markedly acidic-pH stimulated. Strikingly, pH-dependence was greater in DTB cells, particularly for acidic pH values (5.0-6.0).…”
Section: Clinical Anthropometric and Demographic Characteristics Ofmentioning
confidence: 88%
“…Finally, a 4-h exposure of BeWo cells to 1 or 10 μg/ml LPS concentrations known to induce proinflammatory cytokine (interleukin-6 and TNF-α) secretion in trophoblast cells (18) and to 300 ng/l TNF-α itself significantly reduced 3 We next tested the effect of selected GDM conditions on the kinetic parameters of 3 H-FA uptake in BeWo cells. A 4-h and a 24-h treatment with 1 and 100 ng/ml leptin, respectively, and a 4-h treatment with 10 μg/ml LPS did not alter the K m and V max of 3 H-FA uptake by this cell line (data not shown).…”
Section: Hyperleptinemia and Inflammatory Markers Modulate 3 H-fa Uptmentioning
confidence: 99%
See 2 more Smart Citations